|Min SIP Amount||Not Supported|
|NAV||₹301.41 (26 Oct 2020)|
|Fund Started||25 Sep 2018|
|Fund Size||₹3 Cr|
|Divi's Laboratories Ltd.||Healthcare||Equity||5.2%|
|Avenue Supermarts Ltd.||Services||Equity||4.4%|
|Tata Consumer Products Ltd.||FMCG||Equity||4.0%|
|Info Edge (India) Ltd.||Services||Equity||3.4%|
|Aurobindo Pharma Ltd.||Healthcare||Equity||3.0%|
|Pidilite Industries Ltd.||Chemicals||Equity||2.9%|
|Apollo Hospitals Enterprise Ltd.||Healthcare||Equity||2.8%|
|Zee Entertainment Enterprises Ltd.||Services||Equity||2.7%|
SBI ETF Sensex Next 50 Regular Dividend is a ETF Mutual Fund Scheme launched by SBI Mutual Fund. This scheme was made available to investors on 25 Sep 2018. Raviprakash Sharma is the Current Fund Manager of SBI ETF Sensex Next 50 Regular Dividend fund.The fund currently has an Asset Under Management(AUM) of ₹3 Cr and the Latest NAV as of 26 Oct 2020 is ₹301.41.
The SBI ETF Sensex Next 50 Regular Dividend is rated Moderately High risk.
The i scheme seeks to provide returns that, closely correspond to the total returns of the securities as represented by the underlying index, subject to tracking error.